EP Wealth Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-2,385
| Closed | -$254K | – | 880 |
|
2024
Q1 | $254K | Buy |
+2,385
| New | +$254K | ﹤0.01% | 672 |
|
2023
Q4 | – | Sell |
-3,241
| Closed | -$335K | – | 829 |
|
2023
Q3 | $335K | Buy |
3,241
+2,007
| +163% | +$207K | 0.01% | 538 |
|
2023
Q2 | $387K | Sell |
1,234
-130,446
| -99% | -$40.9M | 0.01% | 513 |
|
2023
Q1 | $14M | Buy |
131,680
+129,736
| +6,674% | +$13.8M | 0.24% | 73 |
|
2022
Q4 | $349K | Buy |
+1,944
| New | +$349K | 0.01% | 436 |
|
2022
Q3 | – | Sell |
-1,930
| Closed | -$276K | – | 519 |
|
2022
Q2 | $276K | Buy |
1,930
+472
| +32% | +$67.5K | 0.01% | 496 |
|
2022
Q1 | $251K | Sell |
1,458
-314
| -18% | -$54.1K | 0.01% | 521 |
|
2021
Q4 | $450K | Buy |
1,772
+61
| +4% | +$15.5K | 0.01% | 375 |
|
2021
Q3 | $658K | Buy |
1,711
+60
| +4% | +$23.1K | 0.02% | 293 |
|
2021
Q2 | $388K | Buy |
+1,651
| New | +$388K | 0.01% | 385 |
|